Erschienen in:
13.04.2016 | Original Article – Clinical Oncology
Parotid melanoma of unknown primary
verfasst von:
Jeffrey F. Scott, Cheryl L. Thompson, Ritva Vyas, Kord Honda, Chad Zender, Rod Rezaee, Pierre Lavertu, Henry Koon, Kevin D. Cooper, Meg R. Gerstenblith
Erschienen in:
Journal of Cancer Research and Clinical Oncology
|
Ausgabe 7/2016
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Rarely, melanoma is discovered in the parotid gland without an identifiable primary site. It is not known how patients with parotid melanoma of unknown primary (PMUP) compare to those with a known primary (PMKP). As such, we describe the largest series of patients with PMUP to date and compare them to patients with PMKP.
Methods
We analyzed cases from three sources: (1) the University Hospitals Case Medical Center pathology database (n = 45), (2) the Surveillance, Epidemiology, and End Results 18 database (n = 33), and (3) a comprehensive literature search (n = 32).
Results
PMUP patients were predominately male and presented at a mean age of 56 years. When compared to PMKP, PMUP cases were more likely to be diagnosed in the parotid parenchyma, present with stage IV disease, and develop distant metastases during follow-up in a shorter amount of time. However, there was no difference in overall survival between patients with PMUP and PMKP presenting with stage-matched disease.
Conclusions
Overall survival is similar for stage-matched patients with parotid melanoma presenting with an unknown and known primary site.